Amanta Healthcare received final approval in June 2025 for its IPO comprising a fresh issue of up to 1.25 crore shares. The Ahmedabad-based pharma company refiled its papers in February after withdrawing an earlier filing. It specialises in sterile liquids and parenterals, with over 100 active international registrations.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
